A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study

Coronavirus disease 2019 (COVID‐19) has spread worldwide. To date, no specific drug for COVID‐19 has been developed. Thus, this randomized, open‐label, controlled clinical trial (ChiCTR2000029853) was performed in China. A total of 20 mild and common COVID‐19 patients were enrolled and randomly assi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Zhigang, Luo, Hong, Yu, Zujiang, Song, Jingchao, Liang, Lan, Wang, Ling, Wang, Haiyu, Cui, Guangying, Liu, Yong, Wang, Jin, Li, Qingquan, Zeng, Zhaohai, Yang, Shengkun, Pei, Guangzhong, Zhu, Yonghui, Song, Wenbin, Yu, Wenquan, Song, Chuanjun, Dong, Lihong, Hu, Chuansong, Du, Jinfa, Chang, Junbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404576/
https://www.ncbi.nlm.nih.gov/pubmed/35403380
http://dx.doi.org/10.1002/advs.202001435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404576/
https://www.ncbi.nlm.nih.gov/pubmed/35403380
http://dx.doi.org/10.1002/advs.202001435

Ejemplares similares